Search Results 11-20 of 16158 for brca1%20and%20brca2%20genes%20and%20breast%20cancer

1. Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care - Mayo Clinic News Network

   Many people with VUS may be notified about the reclassification of their VUS as the ClinVar BRCA1/2 expert panel and testing laboratories use the new ...

2. Mastectomy Surgery in Patients with BRCA Gene Mutations - Mayo Clinic

   James W. Jakub, M.D., Breast Surgeon, Mayo Clinic: Patients with a genetic mutation that increase the risk of developing breast cancer have many options to ...

3. Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo Clinic News Network

   Of these, 11 percent had mutations in the BRCA1 and BRCA2 genes and the rest had mutations in 15 other predisposition genes, including the DNA repair genes ...

4. Breast cancer chemoprevention: Drugs that reduce risk - Mayo Clinic

   Preventive medicines can reduce breast cancer risk. Learn about how these medicines work, who should consider taking them, and their side effects and health ...

5. Genetic testing for breast cancer: Psychological and social impact - Mayo Clinic

   Here are some things to think about as you decide whether genetic testing for BRCA1, BRCA2 or the many other genes related to breast cancer is right for you.

6. Phase Ib Study Of Axatilimab In Combination With Olaparib In BRCA1/2 And PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

   Phase Ib Study Of Axatilimab In Combination With Olaparib In BRCA1/2 And PALB2- Associated Metastatic HER2-negative Breast Cancer · Share · Facebook · Twitter.

7. HER2-positive breast cancer: What is it? - Mayo Clinic

   In about 1 of every 5 breast cancers, the cancer cells have extra copies of the gene that makes the HER2 protein. HER2-positive breast cancers tend to be more ...

8. A Study To Compare Two Surgical Procedures In Women With BRCA1 Mutations To Assess Reduced Risk Of Ovarian Cancer - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

9. A Study To Test Adding Pembrolizumab To Olaparib Alone As Therapy For Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations - Mayo Clinic

   The primary purpose of this study is to evaluate the progression free survival (PFS) of advanced pancreatic cancer patients with germline BRCA1 or BRCA2 ...

10. Assessment Of The Efficacy And Safety Of Olaparib Monotherapy Versus Physicians Choice Chemotherapy In The Treatment Of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. - Mayo Clinic

    ... BRCA1/2 Mutations. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.